Invest Clin 65(2): 220 - 229, 2024 https://doi.org/10.54817/IC.v65n2a08
Corresponding Author: Halis Suleyman. Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildi-
rim University, 24100, Erzincan/TĂĽrkiye. Phone: +90 446 2261818, Fax: +90 446 2261819.
E-mail: halis.suleyman@gmail.com
Effect of thiamine pyrophosphate on
oxidative damage in the brain and heart
of rats with experimentally induced
occlusion of the common carotid artery.
Izzet Emir
1
,
Zeynep Suleyman
2
and Halis Suleyman
3
1
Department of Cardiovascular Surgery, Faculty of Medicine, Erzincan Binali Yildirim
University, Erzincan/TĂĽrkiye.
2
Department of Nursing, Faculty of Health Sciences, Erzincan Binali Yildirim University,
Erzincan/TĂĽrkiye.
3
Department of Pharmacology, Faculty of Medicine, Erzincan Binali Yildirim University,
Erzincan/TĂĽrkiye.
Keywords: carotid artery; ıschemia; occlusion; rat; reperfusion; thiamine pyrophosphate.
Abstract. It is known that a sudden increase in cerebral blood flow (hyper-
perfusion) with carotid revascularisation may disrupt and damage the blood-
brain barrier. This study aimed to explore thiamine pyrophosphate’s (TPP) pro-
tective effects against potential brain and heart damage resulting from carotid
cross-clamping and unclamping in rats. The animals were divided into com-
mon carotid cross-clamping and unclamping (CCU), TPP+common carotid
cross-clamping and unclamping (TCCU), and sham operation (SG) groups. The
TCCU group received an intraperitoneal injection (IP) of 20 mg/kg TPP one
hour before anesthesia. The CCU and SG groups received distilled water as a
solvent. Ischemia was induced by maintaining the clips closed for 10 min. For
the SG group, only a subcutaneous incision was made. Afterward, the clips were
removed, the incisions were stitched, and reperfusion was continued for six
hours. Subsequently, the rats were euthanized with high-dosage general anes-
thesia, and heart and brain tissues were removed. TPP significantly suppressed
the I/R-induced malondialdehyde (MDA) increase and decreased total gluta-
thione (tGSH) levels in brain and heart tissues. TPP prevented the increase of
tumor necrosis factor-alpha (TNF-α), interleukin-1 β (IL-1β), and interleukin-6
(IL-6) levels in both brain and heart tissues. In blood serum, TPP suppressed
I/R-induced increase in troponin I (TP I) and creatine kinase-MB (CK-MB) in the
blood. TPP was shown to protect the brain and distant cardiac tissues against
oxidative and inflammatory damage induced by cerebral I/R.
Thiamine pyrophosphate and occlusion of rat carotid artery 221
Vol. 65(2): 220 - 229, 2024
Efecto del pirofosfato de tiamina sobre el daño oxidativo
en el cerebro y el corazĂłn de ratas con oclusiĂłn inducida
experimentalmente de la arteria carĂłtida comĂşn.
Invest Clin 2024; 65 (2): 220 – 229
Palabras clave: arteria carótida; ıschemia; oclusión; rata; reperfusión; pirofosfato
de tiamina.
Resumen. Se sabe que un aumento repentino del flujo sanguĂ­neo cere-
bral (hiperperfusiĂłn) con la revascularizaciĂłn carotĂ­dea puede causar la alte-
ración y daños de la barrera hematoencefálica. El objetivo de este estudio fue
explorar los efectos protectores del pirofosfato de tiamina (TPP) contra los
posibles daños cerebrales y cardíacos resultantes del pinzamiento y despinza-
miento de la carĂłtida en ratas. Los animales se dividieron en grupos de pin-
zamiento y despinzamiento de la carĂłtida comĂşn (CCU), TPP + pinzamiento
y despinzamiento de la carĂłtida comĂşn (TCCU) y operaciĂłn simulada (SG).
El grupo TCCU recibiĂł una inyecciĂłn intraperitoneal (IP) de TPP a una dosis
de 20 mg/kg una hora antes de la anestesia. Los grupos CCU y SG recibieron
agua destilada como disolvente. La isquemia se indujo manteniendo los clips
en posiciĂłn cerrada durante 10 min. En el grupo SG solo se realizĂł una inci-
sión subcutánea. Luego se retiraron los clips, se suturaron las incisiones y se
mantuvo la reperfusiĂłn durante 6 horas. Posteriormente, los animales fueron
sacrificados con altas dosis de anestesia y se extrajeron tejidos del corazĂłn y
del cerebro. El TPP suprimiĂł significativamente el aumento de malondialdehĂ­-
do (MDA) inducido por I/R y la disminuciĂłn de los niveles de glutatiĂłn total
(tGSH) tanto en el tejido cerebral como en el cardĂ­aco. El TPP impidiĂł el au-
mento de los niveles de factor de necrosis tumoral alfa (TNF-α), interleucina
1β (IL-1β) e interleucina-6 (IL-6) en los tejidos del cerebro y del corazón. En
el suero sanguĂ­neo, el TPP suprimiĂł el aumento de la troponina I (TP I) y la
creatina quinasa-MB (CK-MB) inducido por I/R en la sangre. Se demostrĂł que
el TPP protege el cerebro y los tejidos cardíacos distantes contra el daño oxi-
dativo e inflamatorio inducido por la I/R cerebral.
Received: 20-11-2023 Accepted: 13-02-2024
INTRODUCTION
In instances of acute occlusion of the
extracranial internal carotid artery, 40%-60%
of patients experience severe disability, while
16%-55% experience stroke-related compli-
cations that lead to death
1
. As known, ath-
erosclerotic carotid artery disease is a sig-
nificant cause of stroke worldwide
2
. Patients
with severe carotid artery stenosis (≥70%)
have an increased risk of myocardial infarc-
tion and cardiovascular death (22%)
3
. Total
occlusion of the common carotid artery is
rare. However, endarterectomy and endovas-
cular revascularization are recommended in
cases where inadequate cerebral perfusion
leads to various neurological symptoms
4
.
During carotid endarterectomy, cross-clamp-
222 Emir et al.
InvestigaciĂłn ClĂ­nica 65(2): 2024
ing of the carotid artery may induce local
cerebral ischemia, and unclamping may in-
duce ischemia/reperfusion (I/R) injury
5
. A
sudden cerebral blood flow (hyper-perfusion)
increase following carotid revascularization
may disrupt and damage the blood-brain bar-
rier
6
. It is argued that this damage is due to
an increased production of reactive oxygen
species (ROS)
7
. I/R may cause damage not
only in the primary tissue but also in distant
organs
8
. ROS, pro-inflammatory cytokines,
and polymorphonuclear leukocytes are im-
plicated in I/R-related distant organ injury
9,10
. The neutrophil-to-lymphocyte ratio is
recognized as a marker for systemic inflam-
mation and is significantly associated with
postoperative complications
11
. Myocardial
ischemia has been reported to occur with
ST-segment depression during carotid cross-
clamping
12
. These data suggest that severe
cardiac and systemic complications develop
during carotid endarterectomy and endovas-
cular revascularization and that antioxidant
and anti-inflammatory medicines are ben-
eficial in curing cardiac and systemic organ
injury that may develop due to reperfusion.
Myocardial ischemia and hypoxia have been
associated with abnormal increases in TPI
and CK-MB levels
13
. It is known that elevated
levels of TPI and CK-MB are also positively
correlated with elevated levels of oxidants
and pro-inflammatory cytokines
14
.
The current study investigated thia-
mine pyrophosphate (TPP) for its potential
protective effects against cardiac and other
organ damage arising from carotid artery
cross-clamping and unclamping. TPP, the ac-
tive metabolite of thiamine
15
, is synthesized
in the liver through the phosphorylation of
thiamine by thiamine pyrophosphokinase
16
.
Existing literature suggests that TPP exerts a
protective effect by inhibiting the increase in
oxidant and pro-inflammatory parameters
17
.
Furthermore, TPP protects cardiac tissue
from oxidative damage
18
. All these data sug-
gest that TPP is beneficial against possible
cardiac and other organ damage resulting
from carotid cross-clamping and unclamp-
ing. There is a lack of literature investigat-
ing the potential impact of TPP on cardiac
damage caused by carotid cross-clamping
and unclamping procedures. Hence, our
study aimed to biochemically explore TPP’s
protective effects against potential brain
and heart damage from animal carotid cross-
clamping and unclamping.
MATERIALS AND METHODS
Animals
This experimental study, employed 18
male albino Wistar rats weighing 285-298 g.
All experimental rats were sourced from the
Erzincan Binali Yıldırım University Experi-
mental Animals Application and Research
Center. The rats were housed and fed in
groups for one week under standard condi-
tions, including a regular room temperature
(22°C) and a 12-h light/12-h dark cycle to
facilitate environmental adaptation. All pro-
tocols and procedures were confirmed by
the Ethics Committee of the Center for Ani-
mal Experiments (October 27, 2022, Meet-
ing No. 10/53, Approval No. E-85748827-
050.01.04-212799).
Chemicals
The chemicals used in the experiment
and ketamine were sourced from Pfizer Phar-
maceuticals Inc., Sti (TĂĽrkiye), while TPP
was sourced from Biofarma (Russia).
Experimental animals
All experimental rats were divided into
right and left common carotid cross-clamp-
ing and unclamping (CCU), TPP + com-
mon carotid cross-clamping and unclamping
(TCCU), and sham operation (SG) groups.
Experimental Procedures
Surgical operations were done under
sterile conditions in a suitable laboratory
environment. The TCCU (n = 6) group re-
ceived 20 mg/kg TPP intraperitoneally (IP)
one hour before anesthesia. The CCU (n =
6) and SG (n = 6) groups received an equiv-
Thiamine pyrophosphate and occlusion of rat carotid artery 223
Vol. 65(2): 220 - 229, 2024
alent volume of distilled water as a solvent
via the IP route. General anesthesia was
induced with 60 mg/kg of ketamine hydro-
chloride via the IP route. The period during
which the animals remain immobile in the
supine position is considered a suitable an-
esthesia period for surgical intervention
19
.
During this period, rats in all groups were
secured in the supine position on the oper-
ating table, and the midline of the neck was
shaved. After disinfecting this shaved area, a
midline incision was made. After a superfi-
cial microdissection, a deep microdissection
was done on the right common carotid ar-
tery. The trachea was exposed, paratracheal
muscles were dissected to access the com-
mon carotid artery, and a clip was placed on
the common carotid artery. Ischemia was in-
duced by maintaining the clips closed for 10
min. In the SG group, only a subcutaneous
incision was made. At the end of this period,
the clips were removed, the incisions were
sutured, and reperfusion was sustained for
six hours. Subsequently, the rats were eutha-
nized with high-dose anesthesia. The levels
of oxidant/antioxidant markers, including
malondialdehyde (MDA) and total glutathi-
one (tGSH), as well as pro-inflammatory cy-
tokines tumor necrosis factor-alpha (TNF-α),
interleukin-6 (IL-6), and interleukin 1β (IL-
1β), were measured in the extracted brain
and heart tissue samples. Troponin I (TP I)
and creatine kinase-MB (CK-MB) levels were
also investigated in the blood serum. All bio-
chemical results were compared between
the groups.
Biochemical analyses
Preparation of Samples
After rinsing the tissue samples with
physiological saline, they were ground into
powder using liquid nitrogen. Tissue sam-
ples were homogenized to determine GSH,
thiobarbituric acid reactive substances
(TBARS), and protein levels. Clear filtrates
were used to analyze MDA, GSH, and protein
levels.
Quantification of MDA and GSH,
and Protein Levels
MDA and GSH levels in the brain and
heart tissues were quantified following the
(ELISA) kit instructions of the respective
assays (Cayman Chemical Company). Pro-
tein was detected according to the Bradford
method
20
.
TNF-α, IL-1β, and IL-6 Analyses
The tissues were disrupted and homog-
enized by adding liquid nitrogen. We then
added phosphate-buffered saline (pH 7.4)
in a 1/10 (w/v) ratio and vortexed, followed
by centrifugation for 15 min at 15000Ă—g
to collect the supernatant. The samples
were maintained at 2-8°C after melting.
The TNF-α, IL-1β, and IL-6 levels were de-
termined using a commercial ELISA kit sup-
plied by Eastbiopharm Co. Ltd. ELISA kit,
China.
Troponin I (TP I) and Creatine Kinase-MB
(CK-MB) Determination
Blood serum TPI levels were measured
using the enzyme-linked fluorescent assay
technique with the VIDAS TPI Ultra kit and
the ELFA (Enzyme-Linked Fluorescent As-
say) technique. The test was performed au-
tomatically on the VIDAS device using the
ready-to-use test reagents provided in the
kit. The Roche/Hitachi Cobas C 701 system
determined blood serum CK-MB levels. Ac-
cording to the procedure, the test was per-
formed using the immune-UV assay And
ready-to-use test reagents.
Statistical Analyses
The experiment results were presented
as “mean value ± standard deviation” ( ±
SD). The normality test in the groups was
determined by the Shapiro-Wilk test, and the
Levene test determined the homogeneity of
variances. Since the data were normally dis-
tributed, one-way ANOVA was used for all
analyses, and then the Tukey HSD test was
used post-hoc for pairwise. “GraphPad Prism
224 Emir et al.
InvestigaciĂłn ClĂ­nica 65(2): 2024
8 Software” was used. Biochemical results
were analyzed using “IBM SPSS 25.00 (Ar-
monk, NY: IBM Corp)”. P<0.05 was accept-
ed to be significant.
RESULTS
Biochemical Findings
Oxidant/Antioxidant levels in brain tissue
As seen in Table 1, MDA levels in the
brain tissue of animals were significantly
higher in the CCU group than in the sham
operation (SG) group (p<0.001). TPP sig-
nificantly inhibited the increase in MDA lev-
els in the CCU group (p<0.001), and there
was a statistically significant difference in
MDA levels between the TCCU and SG (p =
0.014).
The tGSH, an antioxidant parameter,
significantly decreased in the CCU group
compared to the SG group (p<0.001). The
tGSH level in the TCCU group significant-
ly increased compared to the CCU group
(p<0.001). A statistically significant differ-
ence in tGSH levels was found between the
TCCU and SG groups (p = 0.006).
Pro-inflammatory cytokines levels in brain
tissue
According to Table 1, TNF-α, IL-1β, and
IL-6 levels in the brain tissues of animals
were significantly higher in the CCU group
than in the sham group (p<0.001). TPP ad-
ministration significantly inhibited the in-
crease in pro-inflammatory cytokines levels
in the TCCU group compared to the CCU
group (p<0.001). TNF-α, IL-1β, and IL-6
levels showed statistically significant differ-
ences between the TCCU and SG groups (p
= 0.021; p = 0.001; p = 0.034).
Oxidant/Antioxidant levels in heart tissue
MDA levels in the heart tissues of ani-
mals were significantly higher in the CCU
group than in the SG group (p<0.001).TPP
inhibited the increase in MDA levels in the
CCU group (p<0.001). MDA levels differed
significantly between the TCCU and SG
groups (p = 0.009).
Compared to the SG, the tGSH level
significantly decreased in the CCU group
(p<0.001). Compared to the CCU group,
the tGSH level significantly increased in
Table 1. Biochemical analysis results in the brain and heart tissues and blood serum.
MDA; malondialdehyde, tGSH; total glutathione, TNF-α; tumor necrosis factor alpha, IL-1β; interleukin 1
beta, IL-6; interleukin 6, TP I; Troponin I, CK-MB; Creatine kinase-MB. SG: Sham operation group, CCU:
Common karotis cross-clamping and unclamping, TCCU: TPP + common karotis cross-clamping and
unclamping.
All analysis was done by one-way ANOVA and then Tukey HSD test was used as post-
hoc for for pairwise comparisons (N=6).
Biochemical
parameters
Mean ± Standard Deviation
p values
SG
CCU
TCCU
SG vs. CCU
SG vs.
TCCU
Brain
tissue
MDA
(µmol/g protein)
3.46±0.22
5.87±0.68
3.96±0.39
<0.001
<0.05
tGSH
(nmol/g protein)
4.57±0.12
2.13±0.40
3.95±0.26
<0.001
<0.05
TNF-α
(ng/L)
2.13±0.08
4.51±0.13
2.30±0.06
<0.001
<0.05
IL-1β
(pg/L)
1.80±0.12
4.26±0.07
2.13±0.08
<0.001
<0.001
IL-6
(pg/L)
2.55±0.05
4.70±0.23
2.79±0.07
<0.001
<0.05
Heart
tissue
MDA
(µmol/g protein)
1.60±0.16
3.05±0.14
1.90±0.16
<0.001
<0.05
tGSH
(nmol/g protein)
7.23±0.13
3.65±0.20
6.48±0.23
<0.001
<0.001
TNF-α
(ng/L)
3.30±0.09
6.05±0.34
4.37±0.28
<0.001
<0.001
IL-1β
(pg/L)
2.41±0.19
4.50±0.22
2.70±0.08
<0.001
<0.05
IL-6
(pg/L)
2.19±0.41
4.77±0.16
2.48±0.16
<0.001
>0.05
Blood
serum
TP I
(µg/L)
0.02±0.002
0.04±0.004
0.02±0.003
<0.001
>0.05
CK-MB
(U/L)
40±6.31
82±6.31
44±6.09
<0.001
>0.05
Table 1
Biochemical analysis results in the brain and heart tissues and blood serum.
pairwise comparisons (N=6) “p<0.05 was considered significant”.
Thiamine pyrophosphate and occlusion of rat carotid artery 225
Vol. 65(2): 220 - 229, 2024
the TCCU group (p = 0.001). A statistically
significant difference was observed in tGSH
levels between the TCCU and SG groups
(p<0.001) (Table 1).
Pro-inflammatory levels in heart tissue
As seen in Table 1, TNF-α, IL-1β, and
IL-6 levels in the heart tissues of animals
were significantly higher in the CCU than
in the sham group (p<0.001). Pro-inflam-
matory cytokine levels were significantly
lower in the TCCU than in the CCU group
(p<0.001). TNF-α and IL-1β levels between
the TCCU and SG groups were significantly
different (p<0.001, p = 0.025, respective-
ly), whereas IL-6 levels showed similar values
(p = 0.184).
TP I and CK-MB levels in blood serum
TPI and CK-MB levels in blood serum
were significantly higher in the CCU group
than in the sham group (p<0.001). TPI and
CK-MB levels in the TCCU group significant-
ly decreased compared to those in the CCU
group (p<0.001). There was no significant
difference in TPI and CK-MB levels between
the SG and TCCU groups (p = 0.238; p =
0.550) (Table 1).
DISCUSSION
This study investigated the effect of
TTP against oxidative brain and heart dam-
age resulting from experimentally induced
common carotid artery occlusion in rats
using biochemical methods. The literature
indicates that reversing cerebral blood flow
during reperfusion after ischemia increases
ROS levels
21
. Numerous studies have re-
ported that brain damage resulting from I/R
can impact distant tissues, including the
heart
22,23
. Although many different mecha-
nisms are responsible for the pathogenesis
of distant tissue damage, it has been well es-
tablished that ROS generation is one of the
most frequently observed mechanisms
24
.
ROS react with unsaturated fats in biological
membranes to form MDA, the end product
of lipid peroxidation (LPO)
25
. MDA is a bio-
logical sign of tissue damage and one of the
most significant markers of oxidative dam-
age
21
. Therefore, our study assessed MDA
levels in brain and cardiac tissues using our
I/R model induced by the common carotid
artery occlusion method in rats. Our experi-
mental findings demonstrated a significant
increase in MDA levels in the brain and heart
tissues of rats in the cerebral I/R group com-
pared to the sham group. The literature sug-
gests that increased MDA levels in the brain
due to cerebral I/R are associated with neu-
ronal damage
21,26
. Ojo et al. demonstrated
that brain tissue damage impacted heart
tissue in an I/R model created by bilateral
carotid artery occlusion/reperfusion in rats
24
. They reported cerebral ischemia induces
LPO through increased ROS production in
cardiac tissue, leading to oxidative damage.
Our findings and existing data indicate that
cerebral I/R injury increases ROS, affecting
cardiac tissue.
Conversely, in our study, the admin-
istration of TPP to rats significantly sup-
pressed the I/R-induced increase in MDA
levels in both brain and heart tissues. To
our knowledge, our study is the first to ex-
amine the protective effect of TPP against
cardiac damage caused by common carotid
artery occlusion. Yasar et al. reported that
brain damage caused by focal I/R
27
, and Po-
lat et al. reported that doxorubicin-induced
cardiac toxicity
18
, TPP has a protective ef-
fect against significantly decreasing the in-
creased MDA level. Our experimental results
and existing literature data suggest that TPP
protects the heart from oxidative damage by
significantly reducing LPO during cerebral
I/R, owing to its antioxidant properties.
Excessive ROS production during ce-
rebral I/R causes cell damage by surpassing
the capacity of endogenous antioxidants
21,28
.
Endogenous antioxidants, such as GSH, are
responsible for defense against ROS and are
crucial in protecting brain and heart tissues
against I/R injury
29,30
. GSH is an important
antioxidant enzyme that protects cells from
226 Emir et al.
InvestigaciĂłn ClĂ­nica 65(2): 2024
superoxide and hydroxyl radicals
29,31
. Stud-
ies have associated decreased GSH levels
resulting from cerebral I/R with increased
LPO
32
. Sharipov et al. reported oxidative
damage in the heart mitochondria of rats in
the brain focal I/R model due to an increase
in superoxide and hydroxyl radicals
33
. How-
ever, it was emphasized that decreased GSH
levels in cardiac tissue were associated with
increased MDA levels following cerebral I/R
in rats
24
. Our findings demonstrate reduced
tGSH levels in both brain and heart tissue,
consistent with the literature. This suggests
that tGSH cannot counteract the elevated
ROS levels of I/R. However, TPP significantly
suppressed the I/R injury-related decrease in
tGSH levels in the brain and heart tissues of
rats, which is consistent with previous find-
ings
18,30
demonstrating that TPP prevents
the reduction in GSH levels, exerts antioxi-
dant effects, and thereby protects heart and
brain tissues against oxidative damage. Our
findings suggest that TPP protects against
distant cardiac tissue damage due to cere-
bral I/R by inhibiting LPO and preserving
the antioxidant system.
Ischemia, followed by reperfusion, dis-
rupts the redox balance in favor of pro-oxi-
dants and prompts the release of pro-inflam-
matory cytokines such as TNF-α, IL-β, and
IL-6
34
. Existing studies indicate that TNF-α
is the primary cytokine responsible for stim-
ulating the synthesis of cytokines, such as
IL-β and IL-6, during cerebral I/R.
35,36
TNF-α
and interleukins released due to microglia
and astrocyte activation exacerbate neuroin-
flammation, causing secondary I/R damage
in distant tissues, such as the heart, ulti-
mately leading to cell death
24
. Consistent
with the literature, cerebral I/R significantly
increased TNF-α, IL-1β, and IL-6 levels in
both brain and distant cardiac tissues in our
study. Our findings suggest that I/R injury
begins with oxidative stress and persists due
to inflammation. We examined the impact
of TPP on inflammation and observed that
TPP significantly prevented the increase of
TNF-α, IL-1β, and IL-6 levels in both brain
and heart tissues. While the study by Yasar
et al.
27
showed that TPP significantly sup-
pressed increased TNF-α and IL-1β levels due
to focal I/R injury, there is no study showing
the protective effect of TPP against distant
cardiac tissue damage induced by I/R injury
resulting from bilateral common carotid ar-
tery occlusion.
The bilateral common carotid artery
occlusion procedure led to an increase in se-
rum TPI and CK-MB levels. The significant
increase in TPI and CK-MB levels explains
heart tissue damage and reflects the impact
of the brain I/R event on the heart tissue.
In the literature, abnormal elevation of TPI
and CK-MB levels has been associated with
myocardial ischemia and hypoxia
13
. Further-
more, increased TPI and CK-MB levels cor-
relate positively with increased oxidants and
pro-inflammatory cytokines
14
. The results
of the current experimental study align with
another study
37
, showing that TPI and CK-
MB are associated with increased oxidative
and pro-inflammatory cytokines.
In our study, bilateral common carotid
artery occlusion increased pro-inflammato-
ry cytokine levels in cardiac and brain tis-
sue, accompanied by increased oxidants
and decreased antioxidants. Furthermore,
TPP protects the brain and distant cardiac
tissues against oxidative and inflammatory
damage induced by cerebral I/R. This is the
first study to demonstrate the effect of TPP
against distant tissue heart damage caused
by cerebral I/R injury. However, the current
study suggests that TPP administration re-
duces cardiac damage. The most significant
limitations of this study include the absence
of common carotid occlusion monitoring
and the lack of histopathological examina-
tions. Further studies are necessary to clari-
fy the role of TPP in preventing cerebral I/R
injury and its protective effects on distant
tissue damage.
Thiamine pyrophosphate and occlusion of rat carotid artery 227
Vol. 65(2): 220 - 229, 2024
ACKNOWLEDGMENTS
Thanks to Taha Abdulkadir Coban for
the biochemical analysis of data.
Conflict of interest
None.
ORCID number of authors
• Izzet Emir (IE):
0000-0002-1098-4889
• Zeynep Suleyman (ZS):
0000-0003-0128-7990
• Halis Suleyman (HS):
0000-0002-9239-4099
Participation of authors
Conception and design: IE, HS; Acqui-
sition of data: TAC; Analysis and interpreta-
tion of data: ZS; Drafting of the manuscript:
IE, HS; Critical revision of the manuscript
for important intellectual content: HS; Sta-
tistical analysis: ZS; Final approval of the
submitted manuscript: IE, ZS, HS, TAC.
REFERENCES
1. Benes V3rd, Bradac O, Horvath D, Su-
chomel P, Benes VJr. Surgery of acute oc-
clusion of the extracranial internal carotid
artery - a meta-analysis. Vasa. 2020;49(1):
6-16. doi: 10.1024/0301-1526/a000801
2. Dossabhoy S, Arya S. Epidemiology of
atherosclerotic carotid artery disease.
Semin Vasc Surg. 2021;34(1):3-9. doi:
10.1053/j.semvascsurg.2021.02.013
3. Sirimarco G, Amarenco P, Labreuche J,
Touboul PJ, Alberts M, Goto S, Rother
J, Mas JL, Bhatt DL, Steg PG; REACH
Registry Investigators. Carotid atheros
-
clerosis and risk of subsequent coronary
event in outpatients with atherothrom
-
bosis. Stroke. 2013;44(2): 373-379. doi:
10.1161/STROKEAHA.112.673129
4. Hsu JC, Tsai HL. Endovascular recana
-
lization of common carotid artery Total
occlusion: two case reports and literature
review. CVIR Endovasc. 2020;3(1): 6. doi:
10.1186/s42155-020-0097-6.
5. Kragsterman B, Bergqvist D, Siegbahn
A, Parsson H. Carotid endarterectomy
induces the release of inflammatory
markers and the activation of coagula
-
tion as measured in the jugular bulb. J
Stroke Cerebrovasc. 2017;26(10): 2320-
2328. doi: 10.1016/j.jstrokecerebrovas
-
dis.2017.05.020.
6. Cho HJ, Kim YJ, Lee JH, Choi JW, Moon
WJ, Roh HG, Chun YI, Kim HY. Post-caro
-
tid stenting reperfusion injury with blood-
brain barrier disruption on gadolinium-en
-
hanced FLAIR MRI. BMC Neurol. 2014;14:
178. doi: 10.1186/s12883-014-0178-z
7. Kalimeris K, Kouni S, Kostopanagiotou
G, Nomikos T, Fragopoulou E, Kakisis
J, Vasdekis S, Matsota P, Pandazi A. Cog
-
nitive function and oxidative stress after
carotid endarterectomy: comparison of
propofol to sevoflurane anesthesia. J Car
-
diothor Vasc An. 2013;27(6): 1246-1252.
doi: 10.1053/j.jvca.2012.12.009
8. Blaisdell FW. The pathophysiology of ske
-
letal muscle ischemia and the reperfu-
sion syndrome: a review. Cardiovasc Surg.
2002;10(6): 620-630. doi:10.1016/s0967-
2109(02)00070-4.
9. Katzen BT, MacLean AA. Complications
of endovascular repair of abdominal aor
-
tic aneurysms: a review. Cardiovasc In-
tervent Radiol. 2006;29(6): 935-946. doi:
10.1007/s00270-005-0191-0
10. Onk D, Coskun R, Onk OA, Cimen FK,
Kurt N, Suleyman B, Mammadov R, Al
-
tuner D, Gul V, Malkoc I, Bilgin AO, Su-
leyman H. The effect of esomeprazole on
postoperative pain and lung and heart
complications in rats. Lat Am J Pharm.
2018;37(6):1182-1191.
11. Yu Y, Cui WH, Cheng C, Lu Y, Zhang Q,
Han RQ. Association between neutrophil-
to-lymphocyte ratio and major postoperati
-
ve complications after carotid endarterec-
tomy: A retrospective cohort study. World
J Clin Cases. 2021;9(35):10816-10827.
doi: 10.12998/wjcc.v9.i35.10816
12. Godet G, Bernard JM, Bertrand M, Fus
-
ciardi J, Kieffer E, Coriat P, Petitjean C,
228 Emir et al.
InvestigaciĂłn ClĂ­nica 65(2): 2024
Viars P. Hemodynamic effect of the clam-
ping of the carotid in the surgically treated
coronary patient. Ann Fr Anesth Reanim.
1986;5(5): 473-478. doi: 10.1016/s0750-
7658(86)80031-4.
13. Cordwell SJ, Edwards AVG, Liddy KA,
Moshkanbaryans L, Solis N, Parker BL,
Yong ASC, Wong C, Kritharides L, Ham
-
bly BD, White MY. Release of tissue-spe-
cific proteins into coronary perfusate as
a model for biomarker discovery in myo
-
cardial ischemia/reperfusion injury. J Pro-
teome Res. 2012;11(4): 2114-2126. doi:
10.1021/pr2006928.
14. Mahmoud KM, Ammar AS. Effect of N-ace
-
tylcysteine on cardiac injury and oxidative
stress after abdominal aortic aneurysm re
-
pair: A randomized controlled trial. Acta
Anaesth Scand. 2011;55(8): 1015-1021.
doi: 10.1111/j.1399-6576.2011.02492.x.
15. Sica DA. Loop diuretic therapy, thiami
-
ne balance, and heart failure. Congest
Heart Fail. 2007;13(4): 244-247. doi:
10.1111/j.1527-5299.2007.06260.x.
16. Rindi G, Patrini C, Laforenza U, Mandel
H, Berant M, Viana MB, Poggi V, Zarra
AN. Further studies on erythrocyte thia
-
min transport and phosphorylation in se-
ven patients with thiamin-responsive me-
galoblastic anaemia. J Inherited Metab
Dis;17(6):667-677. doi: 10.1007/BF0071
2009.
17. Ozer M, Ince S, Gundogdu B, Aktas M,
Uzel K, Gursul C, Suleyman H, Suley
-
man Z. Effect of thiamine pyrophospha-
te on cyclophosphamide-induced oxida-
tive ovarian damage and reproductive
dysfunction in female rats. Adv Clin Exp
Med. 2022;31(2): 129-137. doi: 10.17219/
acem/142535.
18. Polat B, Suleyman H, Sener E, Akcay F.
Examination of the effects of thiamine and
thiamine pyrophosphate on doxorubicin-
induced experimental cardiotoxicity. J Car
-
diovasc Pharmacol Ther. 2015;20(2):221-
229. doi: 10.1177/1074248414552901.
19. Kurt A, Isaoglu U, Yilmaz M, Calik M,
Polat B, Hakan H, Ingec M, Suleyman
H. Biochemical and histological investi
-
gation of famotidine effect on postische-
mic reperfusion injury in the rat ovary. J
Pediatr Surg. 2011;46(9): 1817-1823. doi:
10.1016/j.jpedsurg.2011.04.092.
20. Bradford MM. A rapid and sensitive
method for the quantitation of microgram
quantities of protein utilizing the princi
-
ple of protein-dye binding. Anal Biochem.
1976;72:248-254.
21. Ozoner B, Yuceli S, Aydin S, Yazici GN,
Sunar M, Arslan YK, Coban TA, Suleyman
H. Effects of pycnogenol on ischemia/re
-
perfusion-induced inflammatory and oxi-
dative brain injury in rats. Neurosci Lett.
2019;704:169-175. doi: 10.1016/j.neulet.
2019.04.010.
22. Frick T, Springe D, Grandgirard D,
Leib SL, Haenggi M. An improved sim
-
ple rat model for global cerebral ischae-
mia by induced cardiac arrest. Neu-
rol Res. 2016;38(4): 373-380. doi: 10.
1179/1743132815Y.0000000090.
23. Wang R, Liu YY, Liu XY, Jia SW, Zhao J,
Cui D, Wang L. Resveratrol protects neu
-
rons and the myocardium by reducing oxi-
dative stress and ameliorating mitochon-
dria damage in a cerebral ischemia rat
model. Cell Physiol Biochem. 2014;34(3):
854-864. doi: 10.1159/000366304.
24. Ojo OB, Grace Boluwatife Olagunju, Ola
-
jide AO, Jegede ME, Fakorede AS, Crown
OO, Olaleye MT, Akinmoladun AC. Spon
-
dias mombin leaf extract ameliorates ce-
rebral ischemia/reperfusion-induced car-
diohepatorenal oxidative stress in rats.
Phytomedicine Plus. 2022;2(1): 100196.
doi: 10.1016/j.phyplu.2021.100196.
25. Chen CH, Hsieh CL. Effect of acupunctu
-
re on oxidative stress induced by cerebral
ischemia-reperfusion injury. Antioxidants-
Basel. 2020;9(3)248.doi: 10.3390/antiox9
030248.
26. Su D, Li P, Wang X, Zhang W, Zhang YD,
Wu CC, Zhang W, Li Y, Tai WJ, Tang B.
Observing malondialdehyde-mediated sig
-
naling pathway in cerebral ischemia re-
perfusion injury with a specific nanolight.
Anal Chem. 2020;92(3): 2748-2755. doi:
10.1021/acs.analchem.9b05008
27. Yasar H, Demirdogen F, Suleyman B,
Mammadov R, Altuner D, Coban TA, Bu
-
Thiamine pyrophosphate and occlusion of rat carotid artery 229
Vol. 65(2): 220 - 229, 2024
lut S, Gursul C, Suleyman H. Effect of
thiamine pyrophosphate upon oxidative
brain injury induced by ischemia-reperfu
-
sion in rats. Int J Pharmacol. 2023;19(2):
277-285. doi: 10.3923/ijp.2023.277.285
28. Jurcau A, Ardelean AI. Oxidative stress
in ischemia/reperfusion injuries following
acute ischemic stroke. Biomedicines.
2022;10(3):574. doi: 10.3390/biomedici
-
nes10030574
29. Higashi Y, Aratake T, Shimizu T, Shimizu
S, Saito M. Protective role of glutathione
in the hippocampus after brain ischemia.
Int J Mol Sci. 2021;22(15): 7765. doi:
10.3390/ijms22157765.
30. Goshovska YV, Fedichkina RA, Balatskyi
VV, Piven OO, Dobrzyn P, Sagach VF. In
-
duction of glutathione synthesis provides
cardioprotection regulating no, ampk and
ppara signaling in ischemic rat hearts. Life
(Basel). 2021;11(7): 631 doi: 10.3390/
life11070631.
31. He L, He T, Farrar S, Ji LB, Liu TY, Ma X.
Antioxidants maintain cellular redox ho
-
meostasis by elimination of reactive oxygen
species. Cell Physiol Biochem 2017;44(2):
532-553. doi: 10.1159/000485089
32. Wang T, Chen HB, Xia SY, Chen XF, Sun
H, Xu ZX. Ameliorative effect of parishin
c against cerebral ischemia-induced brain
tissue injury by reducing oxidative stress
and inflammatory responses in rat model.
Neuropsych Dis Treat. 2021;17:1811-1823.
doi: 10.2147/NDT.S309065.
33. Sharipov RR, Kotsiuruba AV, Kop”iak BS,
Sahach VF. Induction of oxidative stress
in heart mitochondria in brain focal ische
-
mia-reperfusion and protective effect of
ecdysterone. Fiziol Zh 1994. 2014;60(3):
11-17.
34. Turan MI, Cayir A, Cetin N, Suleyman H,
Siltelioglu Turan I, Tan H. An investiga
-
tion of the effect of thiamine pyrophospha-
te on cisplatin-induced oxidative stress
and DNA damage in rat brain tissue com
-
pared with thiamine: thiamine and thiami-
ne pyrophosphate effects on cisplatin neu-
rotoxicity. Hum Exp Toxicol. 2014;33(1):
14-21. doi: 10.1177/0960327113485251.
35. Jurcau A, Simion A. Neuroinflammation in
cerebral ischemia and ischemia/reperfusion
injuries: from pathophysiology to therapeu
-
tic strategies. Int J Mol Sci. 2021;23(1): 14.
doi 10.3390/ijms230100 14.
36. Zhu H, Hu S, Li Y, Sun Y, Xiong X, Hu X,
Chen J, Qiu S. Interleukins and ischemic
stroke. Front Immunol. 2022;13:828447.
doi: 10.3389/fimmu.2022.828447.
37. Liu SZ, He Y, Shi J, Liu LL, Ma H, He L,
Guo YQ. Allicin attenuates myocardial is
-
chemia reperfusion injury in rats by inhibi-
tion of inflammation and oxidative stress.
Transpl P. 2019;51(6): 2060-2065. doi:
10.1016/j.transproceed.2019.04.039.